Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
Young‐Gyun Seo
Journal of Obesity & Metabolic Syndrome (2020) Vol. 30, Iss. 1, pp. 12-19
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The benefits of GLP1 receptors in cardiovascular diseases
L. Pojskic, Denis Mršić, Amra Macić-Džanković
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 43
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access | Times Cited: 1
360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 21
A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review
Mariana Cornelia Tilinca, Robert Aurelian Tiucă, Alexandru Burlacu, et al.
Medicina (2021) Vol. 57, Iss. 7, pp. 669-669
Open Access | Times Cited: 35
Biaryl carboxamide‐based peptidomimetics analogs as potential pancreatic lipase inhibitors for treating obesity
Vikash Pandey, Patil Amruta Adhikrao, Gudle Mayuri Motiram, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 5
The Therapeutic Potential of GLP-1 Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects
Piotr Krajewski, Aleksandra Złotowska, Jacek C. Szepietowski
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6292-6292
Open Access | Times Cited: 5
Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis
Mark Ayoub, Harleen Chela, Nisar A. Amin, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 944-944
Open Access
Liraglutide-induced oral hyperpigmentation: a case report and review of management strategies
Anhar K. Alzahrani, Mohammad A. Basendwh, Reema S. Alzaidi, et al.
International Journal of Research in Dermatology (2025) Vol. 11, Iss. 3, pp. 257-262
Open Access
Mechanistic Investigation of Huanglian-Wumei in Diabetes Treatment: Integration of LC-MS, Network Pharmacology, and Molecular Docking Approaches
Huili Kang, Panpan Zhang, Y. Jiang, et al.
Natural Product Communications (2025) Vol. 20, Iss. 4
Open Access
Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review
Rutul Gokalani, Mahira Saiyed, Amit Dey, et al.
Deleted Journal (2024) Vol. 1, Iss. 5, pp. 268-272
Open Access | Times Cited: 3
Exploring Side Effects and Discontinuation Reasons of Glucagon-Like-Peptide-1 Agonist (Liraglutide, Semaglutide) for Weight Loss Among Patients at King Abdulaziz University, Jeddah in 2021 to 2023
Nesrain Mubarak Alhamedi
Journal of Clinical Medical Research (2025), pp. 1-12
Closed Access
Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions
Vetriselvan Subramaniyan, Yusoff Umul Hanim
International Journal of Obesity (2025)
Open Access
Signatures of proteomics and glycoproteomics revealed liraglutide ameliorates MASLD by regulating specific metabolic homeostasis in mice
Yuxuan Chen, Chendong Liu, Qian Yang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101273-101273
Open Access
Anti-Obesity Effect of Auricularia delicate Involves Intestinal-Microbiota-Mediated Oxidative Stress Regulation in High-Fat-Diet-Fed Mice
Lanzhou Li, Siyu Zhai, Ruochen Wang, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 872-872
Open Access | Times Cited: 7
Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
Shichao Dong, Chuan Sun
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
Acute Kidney and Liver Injury Associated With Low-Dose Liraglutide in an Obese Adolescent Patient
Rinat Komargodski, Avigail Wittenberg, Hilla Sarig Bahat, et al.
PEDIATRICS (2024) Vol. 154, Iss. 1
Closed Access | Times Cited: 2
Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysis
Hyeon Seok Oh, Minkyu Choi, Tae Suk Lee, et al.
Journal of Analytical Science & Technology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Kamlesh K. Bhopale, Mukund P. Srinivasan
Livers (2023) Vol. 3, Iss. 4, pp. 597-617
Open Access | Times Cited: 6
Comparison of Efficacy of Fermented Garlic and Orlistat (Lipase Inhibitor) in Obesity Management Using an Experimental Rodent Model
Mavra Javed, Waqas Ahmed, Azmatullah Khan, et al.
Foods (2023) Vol. 12, Iss. 21, pp. 3905-3905
Open Access | Times Cited: 4
Liraglutide-Induced Depression with Suicidality in an Obese Adult: A Case Report
Feras Almarshad, Dushad Ram
Galician Medical Journal (2024) Vol. 31, Iss. 2
Open Access | Times Cited: 1
Liubao tea extract restrains obesity-related hyperlipidemia via regulation of AMPK/p38/NF-κB pathway and intestinal microbiota
Xinyu Feng, Y J Qin, MA Shi-cheng, et al.
Food Chemistry (2024) Vol. 464, pp. 141910-141910
Closed Access | Times Cited: 1
Liraglutide effectiveness in preoperative weight-loss for patients with severe obesity undergoing bariatric-metabolic surgery
Martha Patricia Sánchez Muñoz, José Daniel Reyes Blandón, Ileana Susana Camba Gutierrez, et al.
Updates in Surgery (2024) Vol. 76, Iss. 6, pp. 2277-2283
Closed Access | Times Cited: 1
Liraglutide innovations: a comprehensive review of patents (2014–2024)
Ajay Kumar Pandey, Amit K. Goyal
Pharmaceutical Patent Analyst (2024) Vol. 13, Iss. 1-3, pp. 73-89
Closed Access | Times Cited: 1
Application of Machine Learning Methods for the Development of Antidiabetic Drugs
Juanjuan Zhao, Pengcheng Xu, Xiujuan Liu, et al.
Current Pharmaceutical Design (2021) Vol. 28, Iss. 4, pp. 260-271
Closed Access | Times Cited: 5
A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials : Orlistat and body mass index of overweight and obese patients
Jonathan Salim, Sutiono Tandy, Gita Puspitasari
Mediterranean Journal of Nutrition and Metabolism (2024)
Closed Access
Page 1 - Next Page

Scroll to top